Venom

Follow
Illustration of Amazonian scorpion venom research showing potential against breast cancer, with lab equipment and scientists.
Image generated by AI

Amazonian scorpion venom peptide shows paclitaxel-like action against breast cancer cells in lab tests

Reported by AI Image generated by AI Fact checked

Researchers in Brazil have identified a molecule in the venom of the Amazonian scorpion Brotheas amazonicus that kills breast cancer cells in vitro with effects similar to the chemotherapy drug paclitaxel, according to FAPESP. Early tests indicate the peptide chiefly induces necrosis, underscoring venoms’ promise as a source of biopharmaceuticals.

This website uses cookies

We use cookies for analytics to improve our site. Read our privacy policy for more information.
Decline